Differential effects of Ca2+ channel blockers on Ca2+ transients and cell cycle progression in vascular smooth muscle cells

被引:10
作者
Ahmed, A [1 ]
Kobayashi, S [1 ]
Shikasho, T [1 ]
Nishimura, J [1 ]
Kanaide, H [1 ]
机构
[1] Kyushu Univ, Fac Med, Angiocardiol Res Inst, Div Mol Cardiol,Higashi Ku, Fukuoka 81282, Japan
关键词
Ca2+ channel blocker; cell cycle; atherosclerosis; Ca2+; cytosolic; primary culture;
D O I
10.1016/S0014-2999(97)01597-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We examined the differential effects of Ca2+ channel blockers on the elevation of the cytosolic Ca2+ concentration ([Ca2+](i)) and G(0)/G(1) transition induced by platelet-derived growth factor (PDGF) in rat aortic smooth muscle cells in primary culture. The phase of the cell cycle was determined by an immunocytochemical analysis of cell cycle-specific nuclear antigens. [Ca2+](i) was monitored bu fura-3-microfluorometry. The efficacy of Ca2+ channel blockers for the inhibition of [Ca2+](i) elevation induced by PDGF (NiCl2 > isradipine > verapamil = diltiazem) did not parallel that for the inhibition of cell cycle progression induced by PDGF (verapamil = diltiazem > NiCl2 > isradipine). In addition, no significant correlation was observed between the extent of [Ca2+](i) elevation and the extent of G(0)/G(1) transition. We thus conclude that the inhibitory effects of Ca2+ channel blockers on the G(0)/G(1) transition induced by PDGF are not simply due to their inhibitory action on the [Ca2+](i) elevations but instead are due to more complex unknown factors. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 29 条
[1]   DIHYDROPYRIDINE CA2+ CHANNEL ANTAGONISTS INHIBIT THE SALVAGE PATHWAY FOR DNA-SYNTHESIS IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS [J].
AGROTIS, A ;
LITTLE, PJ ;
SALTIS, J ;
BOBIK, A .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 244 (03) :269-275
[2]   LOW-VOLTAGE-ACTIVATED CALCIUM CURRENT IN RAT AORTA SMOOTH-MUSCLE CELLS IN PRIMARY CULTURE [J].
AKAIKE, N ;
KANAIDE, H ;
KUGA, T ;
NAKAMURA, M ;
SADOSHIMA, J ;
TOMOIKE, H .
JOURNAL OF PHYSIOLOGY-LONDON, 1989, 416 :141-160
[3]   CA-2+-CHANNEL BLOCKERS INHIBIT THE ACTION OF RECOMBINANT PLATELET-DERIVED GROWTH-FACTOR IN VASCULAR SMOOTH-MUSCLE CELLS [J].
BLOCK, LH ;
EMMONS, LR ;
VOGT, E ;
SACHINIDIS, A ;
VETTER, W ;
HOPPE, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) :2388-2392
[4]   TRANSCRIPTIONAL ACTIVATION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND CA2+-CHANNEL BLOCKERS INVOLVES PROTEIN-KINASE-C ISOFORMS [J].
BLOCK, LH ;
KEUL, R ;
CRABOS, M ;
ZIESCHE, R ;
ROTH, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) :4097-4101
[5]  
Brocchieri A, 1996, INVAS METAST, V16, P56
[6]   OLEIC-ACID BLOCKS EPIDERMAL GROWTH FACTOR-ACTIVATED EARLY INTRACELLULAR SIGNALS WITHOUT ALTERING THE ENSUING MITOGENIC RESPONSE [J].
CASABIELL, X ;
ZUGAZA, JL ;
POMBO, CM ;
PANDIELLA, A ;
CASANUEVA, FF .
EXPERIMENTAL CELL RESEARCH, 1993, 205 (02) :365-373
[7]   EFFECT OF SR-33805 ON ARTERIAL SMOOTH-MUSCLE CELL-PROLIFERATION AND NEOINTIMA FORMATION FOLLOWING VASCULAR INJURY [J].
DOL, F ;
SCHAEFFER, P ;
LAMARCHE, I ;
MARES, AM ;
CHATELAIN, P ;
HERBERT, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 280 (02) :135-142
[8]   BOMBESIN STIMULATES INTRACELLULAR CA2+ MOBILIZATION BUT NOT PROLIFERATION ON HUMAN COLON-CANCER CELLS [J].
HIRAI, M ;
ISHIZUKA, J ;
HIRAI, A ;
BOLD, RJ ;
TOWNSEND, CM ;
THOMPSON, JC .
LIFE SCIENCES, 1993, 53 (24) :1859-1865
[9]   Endothelin-1 and angiotensin II act as progression but not competence growth factors in vascular smooth muscle cells [J].
Jahan, H ;
Kobayashi, S ;
Nishimura, J ;
Kanaide, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 295 (2-3) :261-269
[10]   QUIN2 MICROFLUOROMETRY AND EFFECTS OF VERAPAMIL AND DILTIAZEM ON CALCIUM RELEASE FROM RAT AORTA SMOOTH-MUSCLE CELLS IN PRIMARY CULTURE [J].
KANAIDE, H ;
KOBAYASHI, S ;
NISHIMURA, J ;
HASEGAWA, M ;
SHOGAKIUCHI, Y ;
MATSUMOTO, T ;
NAKAMURA, M .
CIRCULATION RESEARCH, 1988, 63 (01) :16-26